Study of SGR-1505 in Mature B-Cell Neoplasms
Phase 1
52
about 3 years
18+
16 sites in AZ, DE, FL +10
About this study
This trial is testing a treatment called SGR-1505 for people with certain types of mature B-cell cancers. The goal is to see if the treatment is safe and how well it works, as well as find the highest dose that can be given safely.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take SGR-1505
Participation effort
Estimated from trial records. Details can vary by site.
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Primary: Nature and number of incidences of dose limiting toxicity (DLT)., Nature, severity, and number of incidences of adverse events (AEs), serious AEs (SAEs), and AEs leading to treatment discontinuation.
Secondary: Disease Control Rate, Duration of Response (DOR), Objective Response Rate (ORR), SGR-1505 Area Under the Concentration Versus Time Curve (AUC), SGR-1505 Maximal Plasma Concentration (Cmax), SGR-1505 Time to Maximal Plasma Concentration (tmax)
Oncology